Genocea Biosciences, Inc.

LSE:0A51 Stock Report

Market Cap: US$5.9k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Genocea Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0A51?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders49,8410.0124%
Public Companies4,626,3891.15%
Institutions396,650,50698.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 10 shareholders own 0% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0%
Renta 4 Gestora SGIIC S.A.
396,650,506US$00%0.01%
0%
GSK plc
4,626,389US$00%no data
0%
William Clark
28,205US$00%no data
0%
Girish Aakalu
8,655US$00%no data
0%
Jacquelyn Sumer
5,500US$00%no data
0%
Katrine Bosley
3,887US$00%no data
0%
Thomas Davis
2,526US$00%no data
0%
Jessica Flechtner
514US$00%no data
0%
Diantha Duvall
302US$00%no data
0%
George R. Siber
252US$00%no data